These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 26854486)

  • 1. A Randomized-Controlled Trial of Oral Low-Dose Isotretinoin for Difficult-To-Treat Papulopustular Rosacea.
    Sbidian E; Vicaut É; Chidiack H; Anselin E; Cribier B; Dréno B; Chosidow O
    J Invest Dermatol; 2016 Jun; 136(6):1124-1129. PubMed ID: 26854486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Dose Isotretinoin: An Option for Difficult-to-Treat Papulopustular Rosacea.
    van Zuuren EJ; Fedorowicz Z
    J Invest Dermatol; 2016 Jun; 136(6):1081-1083. PubMed ID: 27212646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the efficacy of topical tretinoin and low-dose oral isotretinoin in rosacea.
    Ertl GA; Levine N; Kligman AM
    Arch Dermatol; 1994 Mar; 130(3):319-24. PubMed ID: 8129410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks.
    Chang AL; Alora-Palli M; Lima XT; Chang TC; Cheng C; Chung CM; Amir O; Kimball AB
    J Drugs Dermatol; 2012 Mar; 11(3):333-9. PubMed ID: 22395584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very low-dose isotretinoin in mild to moderate papulopustular rosacea; a retrospective review of 52 patients.
    Rademaker M
    Australas J Dermatol; 2018 Feb; 59(1):26-30. PubMed ID: 27435665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment of recalcitrant papulopustular rosacea involving pulsed dye laser and fractional microneedling radiofrequency with low-dose isotretinoin.
    Kwon HH; Jung JY; Lee WY; Bae Y; Park GH
    J Cosmet Dermatol; 2020 Jan; 19(1):105-111. PubMed ID: 31102325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosacea treatment with intermediate-dose isotretinoin: follow-up with erythema and sebum measurements.
    Uslu M; Şavk E; Karaman G; Şendur N
    Acta Derm Venereol; 2012 Jan; 92(1):73-7. PubMed ID: 21952746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical metronidazole maintains remissions of rosacea.
    Dahl MV; Katz HI; Krueger GG; Millikan LE; Odom RB; Parker F; Wolf JE; Aly R; Bayles C; Reusser B; Weidner M; Coleman E; Patrignelli R; Tuley MR; Baker MO; Herndon JH; Czernielewski JM
    Arch Dermatol; 1998 Jun; 134(6):679-83. PubMed ID: 9645635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved clinical outcome and biomarkers in adults with papulopustular rosacea treated with doxycycline modified-release capsules in a randomized trial.
    Di Nardo A; Holmes AD; Muto Y; Huang EY; Preston N; Winkelman WJ; Gallo RL
    J Am Acad Dermatol; 2016 Jun; 74(6):1086-92. PubMed ID: 26951940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe papulopustular rosacea successfully treated with a combination of oral azithromycin and isotretinoin.
    Ring HC; Zachariae C; Thomsen SF; Thyssen JP; Egeberg A
    J Dermatolog Treat; 2022 Dec; 33(8):3205-3207. PubMed ID: 36165496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Sarecycline for Treatment of Papulopustular Rosacea: Results of a Pilot Study of Effectiveness and Safety.
    Rosso JQ; Draelos ZD; Effron C; Kircik LH
    J Drugs Dermatol; 2021 Apr; 20(4):426-431. PubMed ID: 33852248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minocycline 1.5% foam for the topical treatment of moderate to severe papulopustular rosacea: Results of 2 phase 3, randomized, clinical trials.
    Gold LS; Del Rosso JQ; Kircik L; Bhatia ND; Hooper D; Nahm WK; Stuart I
    J Am Acad Dermatol; 2020 May; 82(5):1166-1173. PubMed ID: 32004648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azelaic acid foam 15% in the treatment of papulopustular rosacea: a randomized, double-blind, vehicle-controlled study.
    Draelos ZD; Elewski B; Staedtler G; Havlickova B
    Cutis; 2013 Dec; 92(6):306-17. PubMed ID: 24416747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea.
    Erdogan FG; Yurtsever P; Aksoy D; Eskioglu F
    Arch Dermatol; 1998 Jul; 134(7):884-5. PubMed ID: 9681365
    [No Abstract]   [Full Text] [Related]  

  • 15. A Phase II, Randomized, Double-Blind Clinical Study Evaluating the Safety, Tolerability, and Efficacy of a Topical Minocycline Foam, FMX103, for the Treatment of Facial Papulopustular Rosacea.
    Mrowietz U; Kedem TH; Keynan R; Eini M; Tamarkin D; Rom D; Shirvan M
    Am J Clin Dermatol; 2018 Jun; 19(3):427-436. PubMed ID: 29396702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dapsone in rosacea fulminans.
    Bormann G; Gaber G; Fischer M; Marsch WC
    J Eur Acad Dermatol Venereol; 2001 Sep; 15(5):465-7. PubMed ID: 11763393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Severe rosacea treated with oral isotretinoin].
    Gajardo J
    Rev Med Chil; 1994 Feb; 122(2):177-9. PubMed ID: 8085082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial.
    Weissenbacher S; Merkl J; Hildebrandt B; Wollenberg A; Braeutigam M; Ring J; Hofmann H
    Br J Dermatol; 2007 Apr; 156(4):728-32. PubMed ID: 17493072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies.
    Stein L; Kircik L; Fowler J; Tan J; Draelos Z; Fleischer A; Appell M; Steinhoff M; Lynde C; Liu H; Jacovella J
    J Drugs Dermatol; 2014 Mar; 13(3):316-23. PubMed ID: 24595578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea.
    Karabulut AA; Izol Serel B; Eksioglu HM
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):729-34. PubMed ID: 18328059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.